Branebrutinib is under investigation in clinical trial NCT02705989 (Safety, Tolerability and Relative Bioavailability Study of BMS-986195 in Healthy Subjects).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.